Hermona Soreq Selected Research

Cholinergic Antagonists (Anticholinergics)

1/2020	The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
1/2020	Cholino-ncRNAs modulate sex-specific- and age-related acetylcholine signals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hermona Soreq Research Topics

Disease

34	Inflammation (Inflammations) 03/2024 - 11/2004
28	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 05/2005
20	Parkinson Disease (Parkinson's Disease) 01/2023 - 03/2005
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 06/2005
9	Dementia (Dementias) 11/2023 - 01/2013
7	Stroke (Strokes) 01/2021 - 07/2010
6	Myasthenia Gravis 11/2023 - 02/2003
6	Neuroinflammatory Diseases 01/2023 - 01/2014
6	Neoplasms (Cancer) 01/2020 - 12/2002
5	Cognitive Dysfunction 04/2022 - 06/2002
5	Pain (Aches) 01/2022 - 10/2013
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 08/2011
4	Neuroblastoma 11/2023 - 06/2009
4	Epilepsy (Aura) 01/2022 - 02/2008
4	Seizures (Absence Seizure) 01/2017 - 10/2010
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023 - 09/2013
3	Poisoning 07/2023 - 10/2010
3	Multiple Sclerosis 01/2023 - 10/2011
3	Infections 04/2022 - 11/2007
3	Ischemic Stroke 12/2020 - 07/2010
3	Disease Progression 01/2016 - 01/2010
2	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2018
2	Obesity 01/2023 - 10/2022
2	Brain Diseases (Brain Disorder) 12/2022 - 01/2021
2	COVID-19 04/2022 - 01/2020
2	Hypersensitivity (Allergy) 04/2022 - 01/2002
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 07/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018 - 01/2012
2	Wounds and Injuries (Trauma) 02/2012 - 11/2004
2	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2008 - 10/2006
1	Anxiety Disorders (Anxiety Disorder) 01/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Relapsing-Remitting Multiple Sclerosis 01/2023
1	Synucleinopathies 11/2022
1	Proteostasis Deficiencies 11/2022
1	Atrophy 11/2022
1	Weight Loss (Weight Reduction) 10/2022
1	Delirium 04/2022
1	Encephalitis (Encephalitis, Rasmussen) 04/2022

Drug/Important Bio-Agent (IBA)

41	Cholinergic Agents (Cholinergics)IBA 01/2024 - 06/2005
29	MicroRNAs (MicroRNA)IBA 03/2024 - 05/2006
23	AcetylcholinesteraseIBA 01/2024 - 06/2002
18	RNA (Ribonucleic Acid)IBA 11/2023 - 04/2006
17	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2022 - 11/2004
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2002
12	Messenger RNA (mRNA)IBA 01/2024 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2010
10	Transfer RNA (tRNA)IBA 03/2024 - 12/2020
9	Cholinesterases (Cholinesterase)IBA 01/2022 - 07/2010
8	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2023 - 01/2002
8	ButyrylcholinesteraseIBA 07/2014 - 06/2006
6	CytokinesIBA 01/2023 - 12/2009
6	Amyloid (Amyloid Fibrils)IBA 01/2020 - 06/2005
5	Amyloid beta-PeptidesIBA 01/2019 - 06/2006
5	EnzymesIBA 07/2014 - 11/2007
4	LipidsIBA 10/2022 - 07/2010
4	Untranslated RNA (Noncoding RNA)IBA 01/2020 - 01/2014
3	OligonucleotidesIBA 01/2020 - 01/2012
3	Cholinergic ReceptorsIBA 01/2017 - 02/2003
3	EN101IBA 12/2012 - 10/2006
2	SynucleinsIBA 11/2022 - 01/2017
2	LipopolysaccharidesIBA 12/2020 - 01/2016
2	Circular RNAIBA 11/2020 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 10/2019
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 01/2020
2	InflammasomesIBA 01/2019 - 01/2017
2	Kainic Acid (Kainate)IBA 01/2018 - 03/2012
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2018 - 09/2013
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2018 - 08/2012
2	RNA Precursors (Precursor, mRNA)IBA 01/2018 - 06/2008
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018 - 02/2012
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 09/2008
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 01/2016
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2017 - 01/2012
2	Toll-Like Receptor 9IBA 11/2016 - 01/2011
2	AntibodiesIBA 01/2016 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2010
2	RNA Splicing FactorsIBA 01/2016 - 09/2013
2	Peptides (Polypeptides)IBA 06/2008 - 06/2006
2	InsecticidesIBA 06/2006 - 03/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	human MIRN608 microRNAIBA 01/2024
1	Oleic Acid (Oleate)IBA 12/2023
1	Antisense OligonucleotidesIBA 12/2023
1	Perilipin-2IBA 12/2023
1	OximesIBA 07/2023
1	ocrelizumabIBA 01/2023
1	Cladribine FDA LinkGeneric 01/2023
1	InterleukinsIBA 01/2023
1	Caffeine (No Doz)FDA LinkGeneric 01/2023
1	ChemokinesIBA 01/2023
1	Complement System Proteins (Complement)IBA 12/2022
1	Molecular Chaperones (Chaperone, Molecular)IBA 11/2022
1	Intrinsically Disordered ProteinsIBA 11/2022
1	AntioxidantsIBA 01/2022
1	ParaquatIBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022

Therapy/Procedure

10	Therapeutics 01/2023 - 05/2007
5	Deep Brain Stimulation 03/2015 - 07/2012
1	Bariatric Surgery 10/2022